Operating
Net gains (losses) on investments
Gilead Sciences Net gains (losses) on investments decreased by 47.5% to $253.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 300.8%, from -$126.00M to $253.00M. Over 3 years (FY 2021 to FY 2025), Net gains (losses) on investments shows an upward trend with a -9.6% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026
How to read this metric
An increase suggests successful investment performance, though it does not reflect operational cash generation.
Detailed definition
This reflects the non-cash impact of changes in the fair value of equity investments or securities held by the company....
Peer comparison
Varies based on the size of the company's corporate venture capital or treasury investment portfolio.
Metric ID:
cf_gain_loss_on_investmentsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $174.00M | -$142.00M | -$291.00M | -$96.00M | -$303.00M | -$197.00M | -$61.00M | -$256.00M | $69.00M | -$169.00M | -$14.00M | -$391.00M | $257.00M | -$126.00M | -$426.00M | $142.00M | $482.00M | $253.00M |
| QoQ Change | — | -181.6% | -104.9% | +67.0% | -215.6% | +35.0% | +69.0% | -319.7% | +127.0% | -344.9% | +91.7% | <-999% | +165.7% | -149.0% | -238.1% | +133.3% | +239.4% | -47.5% |
| YoY Change | — | — | — | — | -274.1% | -38.7% | +79.0% | -166.7% | +122.8% | +14.2% | +94.5% | -666.7% | +252.1% | — | <-999% | +136.3% | +87.5% | +300.8% |
Range-$426.00M – $482.00M
CAGR+9.2%
Avg YoY Growth-230.9%
Median YoY Growth+79.0%
Net gains (losses) on investments at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's net gains (losses) on investments?
- Gilead Sciences (GILD) reported net gains (losses) on investments of $253.00M in Q4 2025.
- How has Gilead Sciences's net gains (losses) on investments changed year-over-year?
- Gilead Sciences's net gains (losses) on investments increased by 300.8% year-over-year, from -$126.00M to $253.00M.
- What is the long-term trend for Gilead Sciences's net gains (losses) on investments?
- Over 3 years (2021 to 2025), Gilead Sciences's net gains (losses) on investments has grown at a -9.6% compound annual growth rate (CAGR), from -$610.00M to $451.00M.
- What does net gains (losses) on investments mean?
- Non-cash profits or losses from the company's investment portfolio.